Self-reported psychotic experiences in the general population: A valid screening tool for DSM-III-R psychotic disorders?

Acta Psychiatrica Scandinavica

Volumn 107, Issue 5, 2003, Pages 369-377

  Hanssen, M S S ^a   Bijl, R V ^b   Vollebergh, W ^c   Van Os, Jim ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Ministerie van Justitie   (Netherlands)

^c NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnostic test; Psychosis; Screening

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EVIDENCE BASED MEDICINE; EXPERIENCE; FEMALE; HUMAN; INFORMED CONSENT; INTERVIEW; MALE; MENTAL HEALTH SERVICE; NORMAL HUMAN; POPULATION; PRIORITY JOURNAL; PROBABILITY; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RATING SCALE; SCREENING; SELF REPORT; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; AGED; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0038136799     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2003.00058.x     Document Type: Article

References (49)

1. VERDOUX H. Have the times come for early intervention in psychosis? Acta Psychiatr Scand 2001;103:321-322.
2. MCGORRY P. Rationale for and the substantial potential benefits linked to early recognition and optimal treatment of psychotic disorders, specifically schizophrenia. Acta Psychiatr Scand 2001;103:402-403.
3. FALLOON IR. Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry 1992;55:4-15.
4. YUNG AR, PHILLIPS LJ, MCGORRY PD et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 1998;172:14-20.
5. HAEFNER J, LOEFFLER W, MAURER K, HAMBRECHT M, AN DER HEIDEN W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999;100:105-118.
6. LARSEN TK, FRIIS S, HAAHR U et al. Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 2001;103:323-334.
7. MCGORRY PD, MCFARLANE C, PATTON GC et al. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr Scand 1995;92:241-249.
8. CHAPMAN LJ, EDELL WS, CHAPMAN JP. Physical anhedonia, perceptual aberration, and psychosis proneness. Schizophr Bull 1980;6:639-653.
9. CHAPMAN LJ, CHAPMAN JP, KWAPIL TR, ECKBLAD M, ZINSER MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol 1994;103:171-183.
10. KWAPIL TR, MILLER MB, ZINSER MC, CHAPMAN J, CHAPMAN LJ. Magical ideation and social anhedonia as predictors of psychosis proneness: a partial replication. J Abnorm Psychol 1997;106:491-495.
11. PHILLIPS LJ, YUNG AR, MCGORRY PD. Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry 2000;34(suppl.):S164-S169.
12. CARR V, HALPIN S, LAU N, O'BRIEN S, BECKMANN J, LEWIN T. A risk factor screening and assessment protocol for schizophrenia and related psychosis. Aust N Z J Psychiatry 2000;34(suppl):S170-S180.
13. MCGORRY PD. The nature of schizophrenia: signposts to prevention. Aust N Z J Psychiatry 2000;34(suppl.):S14-S21.
14. JENNER JA, VAN DE WILLIGE G. HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study. Acta Psychiatr Scand 2001;103:148-152.
15. POULTON R, CASPI A, MOFFITT TE, CANNON M, MURRAY R, HARRINGTON H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 2000;57:1053-1058.
16. EATON WW, ROMANOSKI A, ANTHONY JC, NESTADT G. Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis 1991;179:689-693.
17. VAN OS J, VERDOUX H, MAURICE-TISON S et al. Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol 1999;34:459-463.
18. MEEHL PE. Schizotaxia revisited. Arch Gen Psychiatry 1989;46:935-944.
19. VAN OS J, TAKEI N, VERDOUX H, DELESPAUL P. Early detection of schizophrenia (letter, comment). Br J Psychiatry 1997;170:579.
20. SUSSER ES, STRUENING EL. Diagnosis and screening for psychotic disorders in a study of the homeless. Schizophr Bull 1990;16:133-145.
21. KLOSTERKOTTER J, HELLMICH M, STEINMEYER EM, SCHULTZELUTTER F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001;58:158-164.
22. GOLDBERG D, HUXLEY P. Mental illness in the community: The pathway to psychiatric care, London, New York: Tavistock Publications, 1980.
23. MILLER PM, LAWRIE SM, BYRNE M, COSWAY R, JOHNSTONE EC. Self-rated schizotypal cognitions, psychotic symptoms and the onset of schizophrenia in young people at high risk of schizophrenia. Acta Psychiatr Scand 2002;105:341-345.
24. BIJL RV, RAVELLI A, VAN ZESSEN G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587-595.
25. BIJL RV, VAN ZESSEN G, RAVELLI A, DE RIJK C, LANGENDOEN Y. The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 1998;33:581-586.
26. GOLDBERG D, WILLIAMS P. User's guide to the GHQ. Windsor: NFER-Nelson, 1988.
27. ROBINS LN, WING J, WITTCHEN HU et al. The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988;45:1069-1077.
28. WORLD HEALTH ORGANISATION. Composite International Diagnostic Interview (CIDI), Version 1.0. Geneva: World Health Organisation, 1990.
29. SMEETS RMW, DINGEMANS PMAJ. Composite International Diagnostic Interview (CIDI), Versie 1.1. Amsterdam/Geneve: World Health Organisation, 1993.
30. WITTCHEN HU, ROBINS LN, COTTLER LB, SARTORIUS N, BURKE JD, REGIER D. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials (Published erratum in Br J Psychiatry 1992;160(January):136). Br J Psychiatry 1991;159:645-653.
31. COTTLER LB, ROBINS LN, GRANT BF et al. The CIDI-core substance abuse and dependence questions: cross-cultural and nosological issues. Br J Psychiatry 1991;159:653-658.
32. SEMLER G, VON CRANACH M, WITTCHEN H-U. Comparison between the Composite International Diagnostic Interview and the Present State Examination. Report to the WHO/ADAMHA task force on instrument development. Geneva: World Health Organisation, 1987.
33. WACKER HR, BATTEGAY R, MULLEJANS R, SCHLOSSER C. Using the CIDI in the general population. In: STEFANIS CN, RABAVILAS AD, SOLDATOS CR, eds Psychiatry: a world perspective. Amsterdam: Elsevier Science Publishers, 1990: 138-143.
34. WITTCHEN HU. Reliability and validity studies of the WHO - Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994;28:57-84.
35. EATON WW, NEUFELD K, CHEN LS, CAI G. A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry 2000;57:217-222.
36. ANTHONY JC, FOLSTEIN M, ROMANOSKI AJ et al. Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in Eastern Baltimore. Arch Gen Psychiatry 1985;42:667-675.
37. HELZER JE, ROBINS LN, MCEVOY LT et al. A comparison of clinical and diagnostic interview schedule diagnoses. Physician reexamination of lay-interviewed cases in the general population. Arch Gen Psychiatry 1985;42:657-666.
38. COOPER L, PETERS L, ANDREWS G. Validity of the Composite International Diagnostic Interview (CIDI) psychosis module in a psychiatric setting. J Psychiatr Res 1998;32:361-368.
39. SPITZER RL, WILLIAMS JB, GIBBON M, FIRST MB. The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description. Arch Gen Psychiatry 1992;49:624-629.
40. StataCorp. STATA - Statisctical Software, Release 7.0. College Station, TX: Statacorp, 2001.
41. SACKETT DL, RICHARDSON WS, ROSENBERG W, HAYNES RB. Evidence-based medicine. New York: Churchill Livingstone, 1997.
42. HENNEKENS CH, BURING JE. Epidemiology in medicine. Boston/Toronto: Little, Brown and Co., 1987.
43. KENDLER KS, GALLAGHER TJ, ABELSON JM, KESSLER RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 1996;53:1022-1031.
44. BEBBINGTON P, NAYANI T. The Psychosis Screening Questionnaire. Int J Methods Psychiatr Res 1995;5:11-19.
45. SHAM PC, JONES P, RUSSELL A, SPELLMAN M, O'HARE A, WALSH D. The Roscommon Family Study. II. Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis study. Br J Psychiatry 1994;165:466-473.
46. KENDLER KS, MCGUIRE M, GRUENBERG AM et al. The risk of nonschizophrenic nonaffective psychoses in relatives. Arch Gen Psychiatry 1993;50:645-652.
47. BAK M, VAN DER SPIL F, GUNTHER N, RADSTAKE S, DELESPAUL P, VAN OS J. Maastricht Assessment of Coping Strategies (MACS-I): a brief instrument to assess coping with psychotic symptoms. Acta Psychiatr Scand 2001;103:453-459.
48. BAK M, VAN DER SPIL F, GUNTHER N, RADSTAKE S, DELESPAUL P, VAN OS J. MACS-II: does coping enhance subjective control over psychotic symptoms? Acta Psychiatr Scand 2001;103:460-464.
49. TERRY MB, NEUGUT AI, SCHWARTZ S, SUSSER E. Risk factors for a causal intermediate and an endpoint: reconciling differences. Am J Epidemiol 2000;151:339-345.